Commentary

Nulla eu felis ligula. Nulla porttitor sapien auctor odio lobortis sagittis. Nulla facilisi. Etiam aliquet arcu ac tempor luctus. Nunc eleifend mi faucibus tellus maximus, sed auctor turpis faucibus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis velit vel erat maximus feugiat nec vitae lacus. Nulla facilisi.

Sed quis vestibulum mauris. Fusce varius cursus est, ac auctor lorem rutrum sit amet. Suspendisse vel lacus eget libero auctor aliquam at nec sapien. Donec auctor, neque in tincidunt mollis, quam leo sagittis nisl, a tempor velit nunc at dui. Morbi malesuada sit amet ligula vel euismod. Cras porttitor orci non justo imperdiet vulputate. Morbi in nibh pretium, finibus augue rhoncus, pulvinar lectus. Nunc sollicitudin tempor volutpat.

19 Nov

Posted at 15:47h in Portfolio Updates

All Reports and Publications and Communications with members are subject to our TERMS OF SERVICE AGREEMENT Quick updates on a few positions of note: I will again reiterate that multiple companies I profiled this year at one point had huge moves up like BIVI, GBOX, MEEC etc,...

10 Nov

Posted at 09:51h in Portfolio Updates

The sun is about to come out on some of our beat down stocks if I'm right, nearing the finish line on several plus great news on some recent positions CARG, DEFTF, ATOM Things are turning around for small caps and we have RSASF announcing a...

04 Nov

Posted at 13:42h in Portfolio Updates

  PCSA had early results on 2 cohorts (Patients) in their 6422 trials, and essentially are holding off on enrolling the 3rd person while they make a few tweaks to dosing and timelines along with discussions with FDA. The early results are strong and this could...

03 Nov

Posted at 08:56h in Portfolio Updates

Some developments on a few positions to update quickly: Working on new ideas for the portfolio, the Biotech I noted has ran up about 33% and I am watching now instead of putting out the report. Prefer a better entry, may or may not get it...

01 Nov

Posted at 08:19h in Portfolio Updates

DEFTF 2.42- 3.50 Wave 3 near term possible Written up on October 12th at 1.66 a share, now 2.42 up 50% already. I have continued to buy the shares almost daily since the day of the report at really any price. I spoke with CEO Russell Starr...

TPS
Tipping Point Stocks

Contact us at
support@TippingPointStocks.com
with any questions. We respond
within 5-15 minutes usually.

This material should not be considered investment advice. The Market Analysts Group, LLC, TippingPointStocks.com, Stockreversalspremium.com , StockReversals.com and or any of our affiliates are not a registered investment advisor. Under no circumstances should any content from this website, articles, videos, seminars or emails from TippingPointStocks.com, Stockreversals.com or Stockreversalspremium.com or any of its affiliates be used or interpreted as a recommendation to buy or sell any type of security or commodity contract. This material is not a solicitation for a trading approach to financial markets. Any investment decisions must in all cases be made by the reader or by his or her registered investment advisor. This information is for educational purposes only. All communications are subject to our Terms of Use Agreement

Disclaimer: CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

All communications are subject to our terms of use agreement

indian xxnx horny desi indian cheating slime wife show boobs in webcam.